Quandt Zoe

Department of Epidemiology, Columbia University Medical Center, Mailman School of Public Health, New York, NY, USA, zquandt@stanford.edu.

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers13 papers

Sort

By YearBy Citation

Author response: Identification of novel, clinically correlated autoantigens in the monogenic autoimmune syndrome APS1 by proteome-wide PhIP-Seq

Sara E Vazquez, Elise Mn Ferré,David W Scheel, Sara Sunshine, Brenda Miao,Caleigh Mandel-Brehm,Zoe Quandt,Alice Y Chan,Mickie Cheng,Michael German,Michail Lionakis,Joseph L DeRisi

eLife, (2020)

Bibtex

SAT-418 Finding the Needles in the Haystack: Harnessing the Electronic Health Record to Find Thyroid Immune Related Adverse Events

Zoe Quandt,Laura Trupin,Michael Evans,Gabriela Schmajuk, Mark Stuart Anderson, Jeff A Bluestone,Yazdany Jinoos

Journal of the Endocrine Society, (2020)

Bibtex

SUN-298 Spectrum of Imaging in Immune Checkpoint Inhibitor Induced Hypophysitis

Zoe Quandt, Stephanie Kim, Javier Villanueva-Meyer, Catherine Coupe, J Blake Tyrrell, Jeffery A Bluestone, Mark Stuart Anderson,Umesh Masharani

Journal of the Endocrine Society, (2020)

Bibtex

Autoimmune Endocrinopathies: An Emerging Complication of Immune Checkpoint Inhibitors

Zoe Quandt, Arabella Young, Ana Luisa Perdigoto,Kevan C Herold,Mark S Anderson

Annual review of medicine, no. 1 (2020)

WOSBibtex

Immune Checkpoint Inhibitor Diabetes Mellitus: A Novel Form of Autoimmune Diabetes

Zoe Quandt, Arabella Young,Mark Anderson

Clinical and Experimental Immunology, (2020)

Bibtex

Elastase 3B mutation links to familial pancreatitis with diabetes and pancreatic adenocarcinoma

Paul C Moore, Jessica T Cortez,Chester E Chamberlain, Diana Alba, Amy C Berger,Zoe Quandt, Alice Chan, Mickie H Cheng, Jhoanne L Bautista, Justin Peng, Michael S German,Mark Anderson

The Journal of clinical investigation, no. 11 (2019)

WOSBibtex

Checkpoint inhibitor-induced insulin-dependent diabetes: an emerging syndrome

Ana Luisa Perdigoto,Zoe Quandt,Mark Anderson,Kevan C Herold

The lancet. Diabetes & endocrinology, (2019)

WOSBibtex

Phase 2 trial of pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC): Clinical outcomes and biomarker analyses

Emily Mitchell,Spencer C. Behr,Jimmy Hwang, Bridget Keenan,Sarah E. Umetsu,John D. Gordan,Andrew H. Ko,Pelin Cinar,Chloe Evelyn Atreya,Katherine Van Loon, Thomas Weber, Zoe Ngo

Journal of Clinical Oncology, (2018): 4087-4087

Bibtex

Phase II trial of pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC)

Emily Mitchell,Spencer C. Behr,Jimmy Hwang, Bridget Keenan, Alexander Cheung,John D. Gordan,Andrew H. Ko,Pelin Cinar,Chloe Evelyn Atreya,Katherine Van Loon, Thomas R. Weber, Zoe Ngo

Journal of Clinical Oncology, (2018)

Bibtex

The Balancing Act between Cancer Immunity and Autoimmunity in Response to Immunotherapy

Arabella Young,Zoe Quandt,Jeffrey A Bluestone

Cancer immunology research, no. 12 (2018): 1445-1452

Cited by1WOSBibtex

Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors

Angeliki M Stamatouli,Zoe Quandt, Ana Luisa Perdigoto,Pamela L Clark,Harriet Kluger,Sarah A Weiss, Scott Gettinger,Mario Sznol, Arabella Young,Robert Rushakoff,James Lee,Jeffrey A Bluestone

Diabetes, (2018)

Cited by14WOSBibtex

Spontaneous tumor lysis syndrome in a patient with metastatic prostate cancer

Naomi Serling-Boyd,Zoe Quandt, Nazima Allaudeen

Molecular and clinical oncology, no. 4 (2017): 589-592

Cited by2WOSBibtex

The association of alcohol consumption with mammographic density in a multiethnic urban population

Zoe Quandt,Julie D Flom,Parisa Tehranifar,Diane Reynolds,Mary Beth Terry,Jasmine A McDonald

BMC cancer, no. 1 (2015): 1094-1094

Cited by4WOSBibtex

View All

Base Info Papers Patents Projects